What is the current valuation of the Animal Model for Testing Market?

The market valuation was 2.09 USD Billion in 2024. Read More

What is the projected market size for the Animal Model for Testing Market by 2035?

The projected valuation for 2035 is 6.018 USD Billion. Read More

What is the expected CAGR for the Animal Model for Testing Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 10.09%. Read More

Which companies are considered key players in the Animal Model for Testing Market?

Key players include Charles River Laboratories, Envigo, Taconic Biosciences, and others. Read More

What are the primary segments of the Animal Model for Testing Market?

The market segments include Animal Type, Application, Technology, End-User, and Modality. Read More

How do rodent models perform in terms of market valuation?

Rodent models, specifically mice and rats, had a valuation of 1.045 USD Billion in 2024 and are projected to reach 2.845 USD Billion. Read More

What is the market valuation for non-rodent animal models?

Non-rodent models, including rabbits, dogs, and primates, were valued at 1.045 USD Billion in 2024 and are expected to grow to 3.173 USD Billion. Read More

Which application segment shows the highest growth potential in the market?

The Drug Discovery and Development segment had a valuation of 0.83 USD Billion in 2024 and is projected to reach 2.4 USD Billion. Read More

What is the valuation trend for genetically modified animal models?

Genetically modified animal models were valued at 0.75 USD Billion in 2024 and are expected to grow to 2.25 USD Billion. Read More

How do academic research institutions contribute to the market?

Academic research institutions had a market valuation of 0.21 USD Billion in 2024 and are projected to reach 0.6 USD Billion. Read More

Animal Model For Testing Market

ID: MRFR/HC/39411-HCR

128 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Animal Model for Testing Market Research Report By Animal Type (Rodents (Mice and Rats), Non-Rodents (Rabbits, Dogs, and Primates)), By Application (Drug Discovery and Development, Toxicity Testing, Safety Assessment, Disease Modeling), By Technology (Genetically Modified Animal Models, Non-Genetically Modified Animal Models, Patient-Derived Xenograft (PDX) Models), By End-User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutions), By Modality (In Vivo, In Vitro, Ex Vivo) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035.

Animal Model For Testing Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Healthcare, BY Animal Type (USD Billion)
4.1.1 Rodents (Mice and Rats)
4.1.2 Non-Rodents (Rabbits, Dogs, and Primates)
4.2 Healthcare, BY Application (USD Billion)
4.2.1 Drug Discovery and Development
4.2.2 Toxicity Testing
4.2.3 Safety Assessment
4.2.4 Disease Modeling
4.3 Healthcare, BY Technology (USD Billion)
4.3.1 Genetically Modified Animal Models
4.3.2 Non-Genetically Modified Animal Models
4.3.3 Patient-Derived Xenograft (PDX) Models
4.4 Healthcare, BY End-User (USD Billion)
4.4.1 Pharmaceutical Companies
4.4.2 Biotechnology Companies
4.4.3 Contract Research Organizations (CROs)
4.4.4 Academic Research Institutions
4.5 Healthcare, BY Modality (USD Billion)
4.5.1 In Vivo
4.5.2 In Vitro
4.5.3 Ex Vivo
4.6 Healthcare, BY Region (USD Billion)
4.6.1 North America
4.6.1.1 US
4.6.1.2 Canada
4.6.2 Europe
4.6.2.1 Germany
4.6.2.2 UK
4.6.2.3 France
4.6.2.4 Russia
4.6.2.5 Italy
4.6.2.6 Spain
4.6.2.7 Rest of Europe
4.6.3 APAC
4.6.3.1 China
4.6.3.2 India
4.6.3.3 Japan
4.6.3.4 South Korea
4.6.3.5 Malaysia
4.6.3.6 Thailand
4.6.3.7 Indonesia
4.6.3.8 Rest of APAC
4.6.4 South America
4.6.4.1 Brazil
4.6.4.2 Mexico
4.6.4.3 Argentina
4.6.4.4 Rest of South America
4.6.5 MEA
4.6.5.1 GCC Countries
4.6.5.2 South Africa
4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Healthcare
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Charles River Laboratories (US)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Envigo (US)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Taconic Biosciences (US)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Harlan Laboratories (US)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Crown Bioscience (US)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 Laboratory Corporation of America (US)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Wuxi AppTec (CN)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Inotiv (US)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY ANIMAL TYPE
6.4 US MARKET ANALYSIS BY APPLICATION
6.5 US MARKET ANALYSIS BY TECHNOLOGY
6.6 US MARKET ANALYSIS BY END-USER
6.7 US MARKET ANALYSIS BY MODALITY
6.8 CANADA MARKET ANALYSIS BY ANIMAL TYPE
6.9 CANADA MARKET ANALYSIS BY APPLICATION
6.10 CANADA MARKET ANALYSIS BY TECHNOLOGY
6.11 CANADA MARKET ANALYSIS BY END-USER
6.12 CANADA MARKET ANALYSIS BY MODALITY
6.13 EUROPE MARKET ANALYSIS
6.14 GERMANY MARKET ANALYSIS BY ANIMAL TYPE
6.15 GERMANY MARKET ANALYSIS BY APPLICATION
6.16 GERMANY MARKET ANALYSIS BY TECHNOLOGY
6.17 GERMANY MARKET ANALYSIS BY END-USER
6.18 GERMANY MARKET ANALYSIS BY MODALITY
6.19 UK MARKET ANALYSIS BY ANIMAL TYPE
6.20 UK MARKET ANALYSIS BY APPLICATION
6.21 UK MARKET ANALYSIS BY TECHNOLOGY
6.22 UK MARKET ANALYSIS BY END-USER
6.23 UK MARKET ANALYSIS BY MODALITY
6.24 FRANCE MARKET ANALYSIS BY ANIMAL TYPE
6.25 FRANCE MARKET ANALYSIS BY APPLICATION
6.26 FRANCE MARKET ANALYSIS BY TECHNOLOGY
6.27 FRANCE MARKET ANALYSIS BY END-USER
6.28 FRANCE MARKET ANALYSIS BY MODALITY
6.29 RUSSIA MARKET ANALYSIS BY ANIMAL TYPE
6.30 RUSSIA MARKET ANALYSIS BY APPLICATION
6.31 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
6.32 RUSSIA MARKET ANALYSIS BY END-USER
6.33 RUSSIA MARKET ANALYSIS BY MODALITY
6.34 ITALY MARKET ANALYSIS BY ANIMAL TYPE
6.35 ITALY MARKET ANALYSIS BY APPLICATION
6.36 ITALY MARKET ANALYSIS BY TECHNOLOGY
6.37 ITALY MARKET ANALYSIS BY END-USER
6.38 ITALY MARKET ANALYSIS BY MODALITY
6.39 SPAIN MARKET ANALYSIS BY ANIMAL TYPE
6.40 SPAIN MARKET ANALYSIS BY APPLICATION
6.41 SPAIN MARKET ANALYSIS BY TECHNOLOGY
6.42 SPAIN MARKET ANALYSIS BY END-USER
6.43 SPAIN MARKET ANALYSIS BY MODALITY
6.44 REST OF EUROPE MARKET ANALYSIS BY ANIMAL TYPE
6.45 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
6.46 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
6.47 REST OF EUROPE MARKET ANALYSIS BY END-USER
6.48 REST OF EUROPE MARKET ANALYSIS BY MODALITY
6.49 APAC MARKET ANALYSIS
6.50 CHINA MARKET ANALYSIS BY ANIMAL TYPE
6.51 CHINA MARKET ANALYSIS BY APPLICATION
6.52 CHINA MARKET ANALYSIS BY TECHNOLOGY
6.53 CHINA MARKET ANALYSIS BY END-USER
6.54 CHINA MARKET ANALYSIS BY MODALITY
6.55 INDIA MARKET ANALYSIS BY ANIMAL TYPE
6.56 INDIA MARKET ANALYSIS BY APPLICATION
6.57 INDIA MARKET ANALYSIS BY TECHNOLOGY
6.58 INDIA MARKET ANALYSIS BY END-USER
6.59 INDIA MARKET ANALYSIS BY MODALITY
6.60 JAPAN MARKET ANALYSIS BY ANIMAL TYPE
6.61 JAPAN MARKET ANALYSIS BY APPLICATION
6.62 JAPAN MARKET ANALYSIS BY TECHNOLOGY
6.63 JAPAN MARKET ANALYSIS BY END-USER
6.64 JAPAN MARKET ANALYSIS BY MODALITY
6.65 SOUTH KOREA MARKET ANALYSIS BY ANIMAL TYPE
6.66 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
6.67 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
6.68 SOUTH KOREA MARKET ANALYSIS BY END-USER
6.69 SOUTH KOREA MARKET ANALYSIS BY MODALITY
6.70 MALAYSIA MARKET ANALYSIS BY ANIMAL TYPE
6.71 MALAYSIA MARKET ANALYSIS BY APPLICATION
6.72 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
6.73 MALAYSIA MARKET ANALYSIS BY END-USER
6.74 MALAYSIA MARKET ANALYSIS BY MODALITY
6.75 THAILAND MARKET ANALYSIS BY ANIMAL TYPE
6.76 THAILAND MARKET ANALYSIS BY APPLICATION
6.77 THAILAND MARKET ANALYSIS BY TECHNOLOGY
6.78 THAILAND MARKET ANALYSIS BY END-USER
6.79 THAILAND MARKET ANALYSIS BY MODALITY
6.80 INDONESIA MARKET ANALYSIS BY ANIMAL TYPE
6.81 INDONESIA MARKET ANALYSIS BY APPLICATION
6.82 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
6.83 INDONESIA MARKET ANALYSIS BY END-USER
6.84 INDONESIA MARKET ANALYSIS BY MODALITY
6.85 REST OF APAC MARKET ANALYSIS BY ANIMAL TYPE
6.86 REST OF APAC MARKET ANALYSIS BY APPLICATION
6.87 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
6.88 REST OF APAC MARKET ANALYSIS BY END-USER
6.89 REST OF APAC MARKET ANALYSIS BY MODALITY
6.90 SOUTH AMERICA MARKET ANALYSIS
6.91 BRAZIL MARKET ANALYSIS BY ANIMAL TYPE
6.92 BRAZIL MARKET ANALYSIS BY APPLICATION
6.93 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
6.94 BRAZIL MARKET ANALYSIS BY END-USER
6.95 BRAZIL MARKET ANALYSIS BY MODALITY
6.96 MEXICO MARKET ANALYSIS BY ANIMAL TYPE
6.97 MEXICO MARKET ANALYSIS BY APPLICATION
6.98 MEXICO MARKET ANALYSIS BY TECHNOLOGY
6.99 MEXICO MARKET ANALYSIS BY END-USER
6.100 MEXICO MARKET ANALYSIS BY MODALITY
6.101 ARGENTINA MARKET ANALYSIS BY ANIMAL TYPE
6.102 ARGENTINA MARKET ANALYSIS BY APPLICATION
6.103 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
6.104 ARGENTINA MARKET ANALYSIS BY END-USER
6.105 ARGENTINA MARKET ANALYSIS BY MODALITY
6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY ANIMAL TYPE
6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USER
6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY MODALITY
6.111 MEA MARKET ANALYSIS
6.112 GCC COUNTRIES MARKET ANALYSIS BY ANIMAL TYPE
6.113 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
6.114 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
6.115 GCC COUNTRIES MARKET ANALYSIS BY END-USER
6.116 GCC COUNTRIES MARKET ANALYSIS BY MODALITY
6.117 SOUTH AFRICA MARKET ANALYSIS BY ANIMAL TYPE
6.118 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
6.119 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
6.120 SOUTH AFRICA MARKET ANALYSIS BY END-USER
6.121 SOUTH AFRICA MARKET ANALYSIS BY MODALITY
6.122 REST OF MEA MARKET ANALYSIS BY ANIMAL TYPE
6.123 REST OF MEA MARKET ANALYSIS BY APPLICATION
6.124 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
6.125 REST OF MEA MARKET ANALYSIS BY END-USER
6.126 REST OF MEA MARKET ANALYSIS BY MODALITY
6.127 KEY BUYING CRITERIA OF HEALTHCARE
6.128 RESEARCH PROCESS OF MRFR
6.129 DRO ANALYSIS OF HEALTHCARE
6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
6.133 HEALTHCARE, BY ANIMAL TYPE, 2024 (% SHARE)
6.134 HEALTHCARE, BY ANIMAL TYPE, 2024 TO 2035 (USD Billion)
6.135 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
6.136 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
6.137 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
6.138 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
6.139 HEALTHCARE, BY END-USER, 2024 (% SHARE)
6.140 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Billion)
6.141 HEALTHCARE, BY MODALITY, 2024 (% SHARE)
6.142 HEALTHCARE, BY MODALITY, 2024 TO 2035 (USD Billion)
6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
7.2.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.2.4 BY END-USER, 2025-2035 (USD Billion)
7.2.5 BY MODALITY, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
7.3.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.3.4 BY END-USER, 2025-2035 (USD Billion)
7.3.5 BY MODALITY, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
7.4.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.4.4 BY END-USER, 2025-2035 (USD Billion)
7.4.5 BY MODALITY, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
7.5.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.5.4 BY END-USER, 2025-2035 (USD Billion)
7.5.5 BY MODALITY, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
7.6.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.6.4 BY END-USER, 2025-2035 (USD Billion)
7.6.5 BY MODALITY, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
7.7.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.7.4 BY END-USER, 2025-2035 (USD Billion)
7.7.5 BY MODALITY, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
7.8.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.8.4 BY END-USER, 2025-2035 (USD Billion)
7.8.5 BY MODALITY, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
7.9.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.9.4 BY END-USER, 2025-2035 (USD Billion)
7.9.5 BY MODALITY, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
7.10.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.10.4 BY END-USER, 2025-2035 (USD Billion)
7.10.5 BY MODALITY, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
7.11.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.11.4 BY END-USER, 2025-2035 (USD Billion)
7.11.5 BY MODALITY, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
7.12.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.12.4 BY END-USER, 2025-2035 (USD Billion)
7.12.5 BY MODALITY, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
7.13.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.13.4 BY END-USER, 2025-2035 (USD Billion)
7.13.5 BY MODALITY, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
7.14.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.14.4 BY END-USER, 2025-2035 (USD Billion)
7.14.5 BY MODALITY, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
7.15.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.15.4 BY END-USER, 2025-2035 (USD Billion)
7.15.5 BY MODALITY, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
7.16.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.16.4 BY END-USER, 2025-2035 (USD Billion)
7.16.5 BY MODALITY, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
7.17.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.17.4 BY END-USER, 2025-2035 (USD Billion)
7.17.5 BY MODALITY, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
7.18.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.18.4 BY END-USER, 2025-2035 (USD Billion)
7.18.5 BY MODALITY, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
7.19.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.19.4 BY END-USER, 2025-2035 (USD Billion)
7.19.5 BY MODALITY, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
7.20.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.20.4 BY END-USER, 2025-2035 (USD Billion)
7.20.5 BY MODALITY, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
7.21.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.21.4 BY END-USER, 2025-2035 (USD Billion)
7.21.5 BY MODALITY, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
7.22.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.22.4 BY END-USER, 2025-2035 (USD Billion)
7.22.5 BY MODALITY, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
7.23.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.23.4 BY END-USER, 2025-2035 (USD Billion)
7.23.5 BY MODALITY, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
7.24.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.24.4 BY END-USER, 2025-2035 (USD Billion)
7.24.5 BY MODALITY, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
7.25.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.25.4 BY END-USER, 2025-2035 (USD Billion)
7.25.5 BY MODALITY, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
7.26.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.26.4 BY END-USER, 2025-2035 (USD Billion)
7.26.5 BY MODALITY, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
7.27.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.27.4 BY END-USER, 2025-2035 (USD Billion)
7.27.5 BY MODALITY, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
7.28.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.28.4 BY END-USER, 2025-2035 (USD Billion)
7.28.5 BY MODALITY, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
7.29.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.29.4 BY END-USER, 2025-2035 (USD Billion)
7.29.5 BY MODALITY, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
7.30.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.30.4 BY END-USER, 2025-2035 (USD Billion)
7.30.5 BY MODALITY, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Animal Type (USD Billion, 2025-2035)

Rodents (Mice and Rats)
Non-Rodents (Rabbits, Dogs, and Primates)

Healthcare By Application (USD Billion, 2025-2035)

Drug Discovery and Development
Toxicity Testing
Safety Assessment
Disease Modeling

Healthcare By Technology (USD Billion, 2025-2035)

Genetically Modified Animal Models
Non-Genetically Modified Animal Models
Patient-Derived Xenograft (PDX) Models

Healthcare By End-User (USD Billion, 2025-2035)

Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations (CROs)
Academic Research Institutions

Healthcare By Modality (USD Billion, 2025-2035)

In Vivo
In Vitro
Ex Vivo

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓